Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus

Vaccine

Volumn 27, Issue 43, 2009, Pages 6004-6010

  Li, Yaoming ^a   Xu, Min ^a   Chen, Long ^a   Zhu, Jinghui ^a   Ye, Jing ^a   Liu, Xueqin ^a   Sun, Yanfang ^a   Chen, Huanchun ^a   Cao, Shengbo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Dendritic cells (DCs); Immunization; Japanese encephalitis virus (JEV); Vaccine

Indexed keywords

GAMMA INTERFERON; INACTIVATED VIRUS VACCINE; INTERLEUKIN 6; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE FREE SURVIVAL; EPIDEMIC ENCEPHALITIS; FEMALE; IN VITRO STUDY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-6; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349298321     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.078     Document Type: Article

References (36)

1. Vaughn D.W., and Hoke C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14 (1992) 197-221
2. Hanna J.N., Ritchie S.A., Phllips D.A., Shield J., Bailey M.C., Mackenzie J.S., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 165 (1996) 256-260
3. World Health Organization. Japanese encephalitis vaccines. Wkly Epidemiol Rec 73 (1998) 334-344
4. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccine. N Engl J Med 319 (1988) 608-614
5. Ku C.C., King C.C., Lin C.Y., Hsu H.C., Chen L.Y., Yueh Y.Y., et al. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol 44 (1994) 122-131
6. Poland J.D., Cropp C.B., Craven R.B., and Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 161 (1990) 878-882
7. Liu Z.L., Hennessy S., Strom B.L., Tsai T.F., Wan C.M., Tang S.C., et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 176 (1997) 1366-1369
8. Hennessy S., Liu Z., Tsai T.F., Strom B.L., Wan C.M., Liu H.L., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347 (1996) 1583-1586
9. Xu G., Xu X., Li Z., He Q., Wu B., Sun S., et al. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 22 (2004) 1846-1853
10. Chang G.J., Hunt A.R., and Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol 74 (2000) 4244-4252
11. Chia S.C., Leung P.S., Liao C.P., Huang J.H., and Lee S.T. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Microb Pathog 31 (2001) 9-19
12. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature Immunol 392 (1998) 245-252
13. Shortman K. Dendritic cells: multiple subtypes, multiple origins, multiple functions. Immunol Cell Biol 78 (2000) 161-165
14. Adema G.J., Hartgers F., Verstraten R., De Vries E., Marland G., Menon S., et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387 (1997) 713-717
15. Macatonia S.E., Doherty T.M., Knight S.C., and O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150 (1993) 3755-3765
16. Salcedo M., Bercovici N., Taylor R., Vereecken P., Massicard S., Duriau D., et al. Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate. Cancer Immunol Immun 55 (2006) 819-829
17. Mbow M.L., Zeidner N., Panella N., Titus R.G., and Piesman J. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect Immun 65 (1997) 3386-3390
18. Moll H. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol Today 14 (1993) 383-387
19. Manickan E.S., Kanangat R.J., Rouse Z., Yu Z., and Rouse B.T. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukocyte Biol 61 (1997) 125-132
20. Kast W.M., Boog C.J., Roep B.O., Voordouw A.C., and Melief C.J. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. J Immunol 140 (1988) 3186-3193
21. Encke J., Findeklee J., Geib J., Pfaff E., and Stremmel W. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clin Exp Immunol 142 (2005) 362-369
22. Andrieu J.M., and Lu W. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results (review). J Intern Med 261 (2007) 123-131
23. Inaba K., Inaba M., Romani N., Aya H., Dequchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 (1992) 1693-1702
24. Tani H., Limn C.K., Yap C.C., Onishi M., Nozaki M., Nishimune Y., et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 77 (2003) 9799-9808
25. Pulendran B., and Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124 (2006) 849-863
26. Steinman R.M., and Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311 (2006) 17-58
27. Steinman R.M., and Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 109 (2002) 1519-1526
28. Lu W., Wu X., Lu Y., Guo W., and Andrieu J.M. Therapytic dendritic-cell vaccine for simian AIDS. Nat Med 9 (2003) 27-32
29. Pulendran B., Palucka K., and Banchereau J. Sensing pathogens and tuning immune responses. Science 293 (2001) 253-256
30. Knight S.C., and Patterson S. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu Rev Immunol 15 (1997) 593-615
31. Moutaftsi M., Mehl A.M., Borysiewicz L.K., and Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. blood 99 (2002) 2913-2921
32. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., and Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186 (1997) 813-823
33. Salio M., Cella M., Suter M., and Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29 (1999) 3245-3253
34. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 163 (1999) 6762-6768
35. Estcourt M.J., Ramshaw A., and Ramsay A.J. Cytokine responses in virus infections: effects on pathogenesis, recovery and persistence. Curr Opin Microbiol 1 (1998) 411-418
36. Li Y.M., Ye J., Cao S.B., Xiao S.B., Zhao Q., Liu X.Q., et al. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. J Gene Med 11 (2009) 57-65